Survival Gains in Gastric Cancer with Surgery and Chemotherapy

Surgery combined with chemotherapy significantly improves survival in gastric cancer patients.

Median survival for intestinal-type cancers was 45.2 months with surgery and chemotherapy, versus just 5.1 months for palliative treatment.
Patients with diffuse-type cancers exceeded 128 months median survival with the same approach, compared to 6.3 months with palliative care.

Palliative chemotherapy and radiotherapy also enhanced survival compared to supportive care alone.

Treatment stage strongly impacts outcomes; advanced stages correlate with lower survival rates.

Journal Article by Kempf ON, Thorsen LBJ (…) Achiam MP et 8 al. in Langenbecks Arch Surg

read the whole article in Langenbecks Arch Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Upper Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Upper Gastrointestinal Tract4 Nov 2026

Dye imaging cuts leaks after oesophagectomy

Checking blood flow with a green fluorescent dye was linked to fewer leaks where the two ends of the oesophagus are joined.

Ann Surg Oncol2 Nov 2026

High symptom burden after oesophagectomy

On postoperative day 3, about one in five patients had high symptom burden, and the symptoms most linked to others differed between patient groups.

Surg Endosc30 Oct 2026

Enhanced recovery after gastrointestinal lesion resection

An enhanced-recovery pathway after endoscopic removal of small upper gastrointestinal lesions shortened hospital stays without increasing complications.

All papers in Upper Gastrointestinal Tract →